Blog
RSS FeedPosted by Michael Wonder on 28 Jul 2017
New drug to help over 200,000 Australians
28 July 2017 - The Australian Government has taken another significant step to eliminate hepatitis C from Australia by subsidising a ...
Posted by Michael Wonder on 27 Jul 2017
£3 a day drug for irritable bowel syndrome gets NICE approval
27 July 2017 - The drug, Truberzi has been recommended for routine funding on the NHS to treat patients with irritable ...
Posted by Michael Wonder on 27 Jul 2017
'We have been waiting for this moment for so long': hepatitis C patients have access to cure with Epclusa PBS listing
28 July 2017 - More than 200,000 Australians with hepatitis C will soon be able to afford a new, highly ...
Posted by Michael Wonder on 27 Jul 2017
Statins should be offered to everyone who has chronic kidney disease, says NICE
27 July 2017 - Healthcare professionals should offer statins to millions of people with chronic kidney disease. ...
Posted by Michael Wonder on 26 Jul 2017
Roche hails 4 year NICE access deal for Gazyvaro
26 July 2017 - NICE has agreed a deal with Roche on its new follicular lymphoma treatment Gazyvaro, giving the ...
Posted by Michael Wonder on 26 Jul 2017
NICE approval for nivolumab provides new treatment for advanced blood cancer
26 July 2017 - People with an advanced type of blood cancer will benefit from nivolumab on the NHS following approval ...
Posted by Michael Wonder on 26 Jul 2017
Post-market review of pulmonary arterial hypertension medicines – public consultation process
26 July 2017 - The public consultation process on the post-market review of the pulmonary arterial hypertension medicines has now ...
Posted by Michael Wonder on 25 Jul 2017
Vismodegib for treatment of patients with basal cell carcinoma
20 July 2017 - The Department of Health has asked the NICE to produce guidance on the use vismodegib in the ...
Posted by Michael Wonder on 25 Jul 2017
The Tasmanian hepatitis C buyers’ club
25 July 2017 - In 2014, when Greg Jefferys’s urine started smelling like dead meat, he knew there was something ...
Posted by Michael Wonder on 25 Jul 2017
Daughters' fight to save father's life
25 July 2017 - When Maria and Loren Calder found out their father had lung cancer, they didn't think they ...
Posted by Michael Wonder on 25 Jul 2017
PBAC to conduct stakeholder forum on the post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis
25 July 2017 - A stakeholder forum will be held for the post-market review of the use of biologics in the ...
Posted by Michael Wonder on 24 Jul 2017
Government moves to legislate to increase generic and biosimilar medicine uptake and cut medicine prices
24 July 2017 - Australia has long lagged behind the USA and UK in its use of generic pharmaceuticals – ...
Posted by Michael Wonder on 24 Jul 2017
NHS England consults on blocking ‘wasteful’ prescriptions
24 July 2017 - NHS England has unveiled detailed proposals of how prescriptions for “ineffective, over-priced and low value treatments” ...
Posted by Michael Wonder on 24 Jul 2017
Managing conflicts of interest – making good decisions
24 July 2017 - NICE is seeking views on a new conflicts of interest policy to ensure its committees’ decisions ...
Posted by Michael Wonder on 24 Jul 2017
Nicotine replacement therapy
21 July 2017 - PHARMAC proposes to continue to fund the Habitrol brand of nicotine gum, lozenges and patches supplied ...